Skip To The Main Content
Parenteral Drug Association Connecting People, Science and Regulation ®

Upcoming Events

View all
View all
View all
View all
View all
PDA ANSI

PDA and the American National Standards Institute (ANSI)

Read more
What's New
  • 2019 PDA Annual Meeting Call for Abstracts is Now Open! Find out more about the abstract submission process, submission deadline, and suggested topics for oral or poster presentations.
  • New online content just added to the PDA Letter! Did you miss the 2018 PDA Visual Inspection Interest Group Workshop? A summary of the event is now available.
  • U.S. FDA Commissioner Scott Gottlieb recently provided an update to the U.S. Congress on the Agency’s implementation of the 21st Century Cures Act. He highlighted the use of real-world evidence and the application of the Regenerative Medicine Advance Therapy designation.
  • The EU and Japan have agreed to broaden the range of medicines covered under the 2004 mutual recognition agreement to include sterile medicines, active pharmaceutical ingredients, and biologics (e.g., vaccines, immunologicals).
Newsfeed
Buyer’s Guide
Become a Member
Borke Van Belle Volunteer Spotlight Volunteer of the Month is Declan Quinlan
PDA Education

Advertisers

Continue the Conversation @PDA ConnectSM An Interactive Online Community!
PDA Career Center

About PDA

The Parenteral Drug Association (PDA) is the leading global provider of science, technology and regulatory information and education for the pharmaceutical and biopharmaceutical community. Founded in 1946 as a nonprofit organization, PDA is committed to developing scientifically sound, practical technical information and resources to advance science and regulation through the expertise of its nearly 10,000 members worldwide.

Read more

PDA Letter Free Articles